Medical Technology

@xconomy.com 4 years ago

With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14

@xconomy.com 5 years ago

At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments

@Primary_Immune 5 years ago

A Medical 'WOW" Moment... A Big Step on the Path to a Diabetes Cure https://www.ucsf.edu/news/2019/02/413186/mature-insulin-producing-cells-grown-lab #ITRTG #BigData #SciComm #MedEd #technology #stemcell #StemCells #biotech #biology #RegenerativeMedicine #RegenMed #genomics #diabetes https://t.co/k4QDH9E6Hg

@xconomy.com 5 years ago

Bio Roundup: Bosley’s Editas Exit, Bridge Bucks, CRISPR Crime & More

@xconomy.com 5 years ago

Deeper Dive: Amarin Fish-Oil Study Gives Eager Doctors More to Ponder

@xconomy.com 5 years ago

With Big Takeda Deal at Launch, Can Ambys Keep Control of Its Future?

@xconomy.com 5 years ago

In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine

@Primary_Immune 6 years ago

Great to See #Israel Researched & Developed #ALS Treatment Making Big US Headlines https://www.bostonglobe.com/business/2018/04/05/trials-for-potential-als-treatment-spark-cautious-hope/ZAqEk7ZfQDcf824MxJF4PO/story.html #ITRTG #StemCell #biotech #RareDisease #genetics #science #innovation #technology #BigData #MND #ישראל - Phase 3 Clinical Trials At 6 Major US Medical Centers https://t.co/jkphWEn6tn

@techcrunch.com 6 years ago

Balderton joins $30M Series D for big data biotech platform play, Sophia Genetics